Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury (SCI)

30 november 2015 uppdaterad av: Richard Schulz, University of Pittsburgh

Caregiver Intervention for Caregivers of SCI Patients

The overall objective of this project is to test the efficacy of an innovative multi-component intervention aimed at reducing the risk for adverse health outcomes among caregivers of older survivors with spinal cord injury or disability, and to improve the well being of the spinal cord-injured survivor. In a three-group, randomized, controlled design providing access to information, resources, and support, we predict that the dual target approach will have a greater positive impact on both the caregiver and survivor than the caregiver-only approach, and that both active treatments will be superior with respect to caregiver outcomes than an information-only control condition.

Studieöversikt

Detaljerad beskrivning

The specific aims of this project are to:

  1. Assess the impact of a dual target (caregiver and care recipient) intervention compared to a traditional caregiver-only intervention strategy.
  2. Assess causal linkages between the treatment components (e.g. knowledge, social support) of a multi-component intervention and specific treatment outcomes (e.g. caregiver depression, quality of life).
  3. Explore cultural and racial differences in the evaluation of and effectiveness of the different treatment approaches.

Overall, the issues affecting management of SCI/D in later life are complex and hold critical implications for the health of the long-term survivor as well as for those who provide care in the home environment. Large numbers of individuals are living with the effects of SCI/D for decades post-injury. In addition to the health-related complications that typically accompany older age, these individuals are especially vulnerable to co-occurring medical conditions that require high degrees of support and maintenance. Consequently, older caregivers face multiple and often extreme challenges in providing support to the SCI/D survivor at a time in their lives when their own abilities may be compromised due to age-related changes in health and functioning.

The multi-faceted burden faced by caregivers is associated with high levels of depression and anxiety as well as the onset of deleterious physical symptoms. The cumulative effects of such multiple stressors over time all too frequently leave the caregiver unable to continue providing the level of support necessary to maintain their partner's health in the home environment. In order to circumvent the additional distress certain to accompany such a family separation, Elliott et al. (2001, p. 230) recently concluded that "there is a pressing need for interventions that help family [SCI] caregivers address the routines and tasks essential to maintaining family functioning."

Studietyp

Interventionell

Inskrivning (Faktisk)

380

Fas

  • Fas 2
  • Fas 3

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Florida
      • Miami, Florida, Förenta staterna, 33136
        • University of Miami
    • Pennsylvania
      • Pittsburgh, Pennsylvania, Förenta staterna, 15260
        • University of Pittsburgh (UCSUR)

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

30 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria (Survivors):

  • have adult-onset disability resulting from spinal cord injury, trauma, or disease,
  • be survivors with complete or incomplete injury as defined by the American Spinal Injury Association (ASIA) impairment scale
  • require and use some type of assistance for getting around (e.g., wheelchair, cane, etc.) be 30 years old or older be living at home for a minimum of 1 year post-injury (to avoid the acute trauma phase) speak English.

Inclusion Criteria (Caregivers):

  • Is a family member/partner (e.g. spouse, child, or fictive kin)
  • is 18 years of age or older
  • is or is not living with the care recipient
  • speaks English
  • has a telephone at home
  • plans to live in the area for at least 6 months.
  • self-identifies as white, African American or Hispanic.

Exclusion Criteria:

  • has a terminal illness with life expectancy of less than 6 months
  • is in active treatment for cancer (except for tamoxifen and lupron)
  • is blind or deaf
  • if the survivor is cognitively impaired due to brain injury or dementia and/or has no use of their hands and severe limitations in speech production

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Caregiver Only
A multi-component psycho-educational intervention designed to reduce the negative emotional and behavioral responses of the caregiver and reduce the risk of mental and physical health problems.
A multi-component psycho-educational intervention designed to reduce the negative emotional and behavioral responses of the caregiver and reduce the risk of mental and physical health problems.
Experimentell: Dual Treatment
Complements the caregiver only intervention by targetting both caregiver and SCI person with multi-component psycho-educational intervention
Complements the caregiver only intervention by targetting both caregiver and SCI person with multi-component psycho-educational intervention
Aktiv komparator: Control
Participants are provided with written materials at beginning of study; nothing thereafter
Participants given written educational materials at beginning of study; no treatment beyond this

Vad mäter studien?

Primära resultatmått

Resultatmått
Tidsram
Depressive symptoms caregivers and SCI
Tidsram: 6 and 12 months post-randomization
6 and 12 months post-randomization
Caregiver Burden
Tidsram: 6 and 12 months
6 and 12 months
Social support caregiver and SCI
Tidsram: 6 and 12 months
6 and 12 months
Health symptoms caregiver and SCI
Tidsram: 6 and 12 months
6 and 12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Samarbetspartners

Utredare

  • Huvudutredare: Richard Schulz, PhD, University of Pittsburgh

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 september 2002

Primärt slutförande (Faktisk)

1 juli 2007

Avslutad studie (Faktisk)

1 juli 2008

Studieregistreringsdatum

Först inskickad

2 september 2005

Först inskickad som uppfyllde QC-kriterierna

6 september 2005

Första postat (Uppskatta)

7 september 2005

Uppdateringar av studier

Senaste uppdatering publicerad (Uppskatta)

2 december 2015

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 november 2015

Senast verifierad

1 november 2015

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 5R01NR008272 (U.S.S. NIH-anslag/kontrakt)

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

produkt tillverkad i och exporterad från U.S.A.

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Ryggmärgsskador

Kliniska prövningar på Caregiver Only Intervention

3
Prenumerera